Shared decision making in consultations about treatment for non small cell lung cancer
Lung Cancer accounts for between 10-15% of all new cases of cancer in the UK. Considering treatment for lung cancer is a complex process involving balancing the trade-off between quality and quantity of life. Guidelines (NICE 2005) emphasise that treatment decision making is an endeavour to be done...
Main Author: | Lifford, Rebecca Elizabeth |
---|---|
Other Authors: | Bekker, H. ; Mulatero, C. |
Published: |
University of Leeds
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.559141 |
Similar Items
-
Analysis of DNA damage and cellular responses to platinum-based chemotherapeutic agents in 'in vitro' models of non-small cell lung cancer
by: Almeida, Gabriela Martinho de
Published: (2005) -
Identification of CTL epitopes in novel tumour antigens for immunotherapy in human lung cancer
by: Darby, Angela J.
Published: (2004) -
Decision-making about treatment for psychosis
by: Stovell, Diana
Published: (2014) -
Decision making about cancer treatment and clinical trial participation
by: Abhyankar, Purva
Published: (2008) -
Patient decision making about dialysis
by: Winterbottom, Anna Elizabeth
Published: (2009)